Long-term metabolic consequences of switching from protease inhibitors to efavirenz in therapy for human immunodeficiency virus-infected patients with lipoatrophy

  1. Estrada, V.
  2. De Villar, N.G.P.
  3. Martínez Larrad, M.T.
  4. González López, A.
  5. Fernández, C.
  6. Serrano-Rios, M.
Journal:
Clinical Infectious Diseases

ISSN: 1058-4838

Year of publication: 2002

Volume: 35

Issue: 1

Pages: 69-76

Type: Article

DOI: 10.1086/340863 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus